Cicatrix  >>  Laviv (autologous fibroblast cell therapy system)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Laviv (autologous fibroblast cell therapy system) / Paragon Biosci, Precigen
NCT00642642: Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring

Checkmark
Apr 2013 - Apr 2013: 
Checkmark P2 data
Aug 2012 - Aug 2012: P2 data
Checkmark P2/3 data
More
Completed
2/3
122
US
Autologous Human Fibroblasts (azficel-T), LAVIV, Placebo
Castle Creek Biosciences, LLC.
Acne Scarring of the Face
03/09
03/09

Download Options